Hori Daijiro, Okamura Homare, Yamamoto Takahiro, Nishi Satoshi, Yuri Koichi, Kimura Naoyuki, Yamaguchi Atsushi, Adachi Hideo
Department of Cardiovascular Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):944-950. doi: 10.1093/icvts/ivx031.
With the introduction of endovascular stent graft technology, a variety of surgical options are available for patients with aortic aneurysms. We sought to evaluate early-term and mid-term outcomes of patients undergoing endovascular and open surgical repair for non-dissected aortic arch aneurysm.
Overall, 200 patients underwent treatment for isolated non-dissected aortic arch aneurysm between January 2008 and February 2016: 133 patients had open surgery and 67, endovascular repair. Early-term and mid-term outcomes were compared.
Seventy percent ( n = 47) needing endovascular repair underwent fenestrated stent graft and 30% ( n = 20) underwent the debranched technique. Patients in the open surgery group were younger (71 vs 75 years, P < 0.001) and had a lower prevalence of ischaemic heart disease (11% vs 35%, P < 0.001). Intensive care unit stay (1 vs 3 days, P < 0.001), hospital stay (11 vs 17 days, P < 0.001) and surgical time (208 vs 390 min, P < 0.001) were lower in the endovascular repair group than in the open surgery group. There were 3 in-hospital deaths each in the open surgery and endovascular groups (2% vs 5%, respectively, P = 0.40). Mid-term survival ( P < 0.001) and freedom from reintervention ( P = 0.009) were better in the open surgery than in the endovascular repair group. No aneurysm-related deaths were observed. The propensity-matched comparison ( n = 58) demonstrated that survival was better in the open surgery group ( P = 0.011); no significant difference was seen in the reintervention rate ( P = 0.28).
Close follow-up for re-intervention may reduce the risk for aneurysm-related deaths and provide acceptable outcomes in patients undergoing endovascular repair.
随着血管内支架移植物技术的引入,腹主动脉瘤患者有多种手术选择。我们试图评估接受血管内修复和开放手术修复的非夹层主动脉弓动脉瘤患者的早期和中期结果。
总体而言,200例患者在2008年1月至2016年2月期间接受了孤立性非夹层主动脉弓动脉瘤的治疗:133例患者接受了开放手术,67例接受了血管内修复。比较早期和中期结果。
需要血管内修复的患者中有70%(n = 47)接受了开窗支架移植物治疗,30%(n = 20)接受了去分支技术治疗。开放手术组患者更年轻(71岁对75岁,P < 0.001),缺血性心脏病患病率更低(11%对35%,P < 0.001)。血管内修复组的重症监护病房住院时间(1天对3天,P < 0.001)、住院时间(11天对17天,P < 0.001)和手术时间(208分钟对390分钟,P < 0.001)均低于开放手术组。开放手术组和血管内修复组各有3例住院死亡(分别为2%和5%,P = 0.40)。开放手术组的中期生存率(P < 0.001)和免于再次干预的比例(P = 0.009)均优于血管内修复组。未观察到与动脉瘤相关的死亡。倾向匹配比较(n = 58)显示,开放手术组的生存率更高(P = 0.011);再次干预率无显著差异(P = 0.28)。
密切随访再次干预可能降低与动脉瘤相关的死亡风险,并为接受血管内修复的患者提供可接受的结果。